RESEARCH
Oncogenic KRAS and BRAF Drive Lactate-Mediated Immune Suppression in Microsatellite-Stable CRCA mechanistic review describes how KRAS and BRAF mutations drive aerobic glycolysis and lactate accumulation, which suppresses T-cell function and contributes to immunotherapy resistance in MSS tumors. (Int J Mol Sci)